Dr Johanna Ramroth
Johanna Rankin Ramroth
As a Statistician-Epidemiologist, who completed her DPhil in December 2018, Johanna Ramroth continues to work with Sarah Darby, Carolyn Taylor, David Cutter and Paul McGale on several studies examining long-term effects of radiotherapy used to treat lung cancer, breast cancer, and lymphomas. She obtained an MSc in Medical Statistics in 2012, and another MSc in Public Health in Developing Countries in 2007, both from the London School of Hygiene and Tropical Medicine. In other lives, she enjoys outdoor sport and the study of language.
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma.
Cutter DJ. et al, (2021), J Clin Oncol, 39, 3591 - 3601
An Excess Mortality Risk Analysis of Proton Beam versus Optimal Photon Radiotherapy for Mediastinal Hodgkin Lymphoma: Who May Benefit Most?
Ntentas G. et al, (2020), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 108, S140 - S141